In a group of 19 patients with both an MSI-high HNPCC-associated tumour and loss of MSH6 expression, but no detectable defect in MLH1 or MSH2, 10 pathogenic mutations in MSH6 were found in nine families (Table 1). This evidence concerns the gene MLH1 and neoplasm.